Ishita Drugs & Industries Share Price
ISHITADR
Live Ishita Drugs & Industries Share Price Chart
Ishita Drugs & Industries Performance
Days Range
| Previous Close | ₹72.30 |
|---|---|
| Open | ₹75.4 |
| Volume | 654 |
| Day's Range | ₹72.50 - ₹75.40 |
|---|---|
| 52W Range | ₹66.00 - ₹90.85 |
| Market Cap | ₹21.62 Cr |
Ishita Drugs & Industries Fundamentals
| ROCE(TTM) | 9.78 |
|---|---|
| P/E Ratio (TTM) | 30.64 |
| P/B Ratio | 1.87 |
| Industry P/E | 50.45 |
| Debt to Equity | 0.01 |
| ROE | 6.73 |
| EPS (TTM) | 2.36 |
| Dividend Yield | N/A |
| Book Value | 38.70 |
| Face Value | 10 |
| ROCE(TTM) | 9.78 |
|---|---|
| P/E Ratio (TTM) | 30.64 |
| P/B Ratio | 1.87 |
| Industry P/E | 50.45 |
| Debt to Equity | 0.01 |
| ROE | 6.73 |
|---|---|
| EPS (TTM) | 2.36 |
| Dividend Yield | N/A |
| Book Value | 38.70 |
| Face Value | 10 |
Ishita Drugs & Industries Financials
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Net Sales | 3.07 | 3.14 | 3.06 | 3.15 |
| Expenses | 2.91 | 3.03 | 2.98 | 2.88 |
| Profit before tax | 0.22 | 0.19 | 0.28 | 0.30 |
| Operating Profit | 0.14 | 0.16 | 0.18 | 0.23 |
| Net Profit | 0.14 | 0.16 | 0.18 | 0.23 |
| EPS in Rs | 0.48 | 0.52 | 0.59 | 0.77 |
Ishita Drugs & Industries Shareholding Pattern
Promoters
50.04%
Retail And Others
49.96%
Foreign Institutional Investors
0.00%
Domestic Institutional Investors
0.00%
About Ishita Drugs & Industries
Ishita Drugs & Industries was incorporated in Feb.'92 by Jagdish Agarwal. The company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.'95.
Recession in some international markets and intense dumping of the Chinese exporters of the bulk drugs originally planned in the product range, necessiated a review by the company of its production programme and product range. It decided to undertake production of fluoro-quinolones, the latest broad spectrum anti-bacterials.
The company established an in-house R&D laboratory which has developed a highly improved process technology for norfloxacin. The in-house process technology for norfloxacin was implemented in its plant in Oct.'95.
Parent Organisation
Indian Private
Managing Director
Jagdish Agrawal
Founded
1992
NSE Symbol
Top Mutual Funds Invested in Ishita Drugs Industries Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,942.0 -2.40 (-0.12%) | ₹4,68,530.14 | 1,548.0 - 2,046.9 |
| Divis Laboratories Ltd | 8,560.0 260.00 (3.13%) | ₹2,19,675.25 | 5,636.5 - 8,585.0 |
| Torrent Pharmaceuticals Ltd | 4,883.0 -41.00 (-0.83%) | ₹1,86,969.82 | 3,480.6 - 5,250.0 |
| Cipla Ltd | 1,463.0 -4.70 (-0.32%) | ₹1,17,945.42 | 1,165.7 - 1,673.0 |
| Zydus Lifesciences Ltd | 1,194.3 75.30 (6.73%) | ₹1,11,790.25 | 835.5 - 1,205.0 |
| Lupin Ltd | 2,278.9 -21.10 (-0.92%) | ₹1,04,020.40 | 1,875.0 - 2,529.5 |
Popular Stocks
Ishita Drugs Industries Ltd FAQs
Can I buy Ishita Drugs Industries Ltd (Ishita Drugs Industries Ltd) from Angel One?
Yes, You can buy Ishita Drugs Industries Ltd (Ishita Drugs Industries Ltd) shares by opening a Demat account with Angel One.
How do I buy Ishita Drugs Industries Ltd (Ishita Drugs Industries Ltd) from Angel One?
Ishita Drugs Industries Ltd (Ishita Drugs Industries Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Ishita Drugs Industries Ltd (Ishita Drugs Industries Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Ishita Drugs Industries Ltd (Ishita Drugs Industries Ltd) shares.
1. Direct investment: You can buy Ishita Drugs Industries Ltd (Ishita Drugs Industries Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Ishita Drugs Industries Ltd (Ishita Drugs Industries Ltd) shares.
